Terns Pharmaceuticals Inc (TERN)
6.55
-0.23
(-3.39%)
USD |
NASDAQ |
Nov 14, 16:00
6.64
+0.09
(+1.37%)
After-Hours: 07:42
Terns Pharmaceuticals Net Income (TTM): -95.90M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -95.90M |
| March 31, 2024 | -91.06M |
| December 31, 2023 | -90.21M |
| September 30, 2023 | -85.01M |
| June 30, 2023 | -72.07M |
| March 31, 2023 | -68.10M |
| December 31, 2022 | -60.34M |
| September 30, 2022 | -58.77M |
| Date | Value |
|---|---|
| June 30, 2022 | -53.79M |
| March 31, 2022 | -50.59M |
| December 31, 2021 | -50.16M |
| September 30, 2021 | -45.84M |
| June 30, 2021 | -45.44M |
| March 31, 2021 | -44.39M |
| December 31, 2020 | -40.05M |
| September 30, 2020 | -39.90M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-95.90M
Minimum
Jun 2024
-39.90M
Maximum
Sep 2020
-61.98M
Average
-56.28M
Median
Net Income (TTM) Benchmarks
| Eli Lilly and Co | 8.370B |
| Viking Therapeutics Inc | -99.15M |
| Biomarin Pharmaceutical Inc | 322.29M |
| Elite Pharmaceuticals Inc | 19.58M |
| Verrica Pharmaceuticals Inc | -84.99M |